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Abstract: Diurnal mood variations are one of the core symptoms in depression, and total sleep
deprivation (SD) can induce rapid, short-lasting clinical improvement in depressed patients. Here,
we investigated if differential sleep pressure conditions impact on subjective mood levels in young
women with major depressive disorder (MDD) without sleep disturbances, and in healthy controls.
Eight healthy and eight MDD women underwent 40-h SD (high sleep pressure) and 40-h multiple
NAP (low sleep pressure) protocols under constant routine conditions during which subjective mood
was assessed every 30-min. MDD women rated overall significantly worse mood than controls,
with minimal values for both groups during the biological night (ca. 4 a.m.), under high and low
sleep pressure conditions. During SD, nighttime mood ratings in MDD women were lower than
in controls and partially recovered during the second day of SD, but never attained control levels.
The degree of this diurnal time-course in mood under SD correlated positively with sleep quality
in MDD women. Our data indicate that MDD women without sleep disturbances did not exhibit
a SD-induced antidepressant response, suggesting that the mood enhancement response to sleep
deprivation might be related to the co-existence of sleep disturbances, which is an association that
remains to be fully established.
Keywords: major depressive disorder; sleep deprivation; mood; circadian rhythms; sleep homeostasis
1. Introduction
Total sleep deprivation (SD) has been described as the most rapid non-pharmacological
antidepressant currently known [1]. Indeed, marked improvements with SD may occur within
hours in approximately 60% of depressive patients (reviewed in [1]). Even though the improvement
following total SD is rapid, there is often a rapid return of depressive symptoms after subsequent
recovery sleep, which suggests that the pathophysiological hallmarks of depression may be linked to
sleep-wake regulatory processes [1]. Additionally, in order to optimize the antidepressant response,
SD needs to coincide with an early morning circadian phase [2].
The theoretical framework for sleep deprivation as a means to improve subjective mood in
depressive patients builds upon the two-process model [3,4] and its ramifications for depression [3,4].
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Briefly, the process S-deficiency hypothesis postulates a deficiency in the homeostatic build-up of sleep
pressure during wakefulness in people suffering with major depressive disorder (MDD), resulting in a
shallower dissipation rate of process S during sleep [3,5]. Variations in homeostatic sleep regulation
can be estimated by spectral electroencephalogram (EEG) activity in the low-frequency range (1–7 Hz)
during both sleep and wakefulness [6,7]. Sleep in depression is often disturbed, as manifested by a
reduction in slow-wave sleep (SWS) and a disinhibition of rapid eye movement sleep (REMS) [8,9]. The
two-process model of sleep-wake regulation was proposed to explain sleep-wake cycle disturbances
in major depression [3]. This model attempts to explain the effects of SD, REM-sleep disinhibition
and reduction of SWS as the result of a deficient sleep homeostatic process that is linked with mood
deterioration in depressive patients [3]. This putative relationship may not necessarily apply to all
types of depression. Indeed, the process S-deficiency hypothesis for MDD has contradictory findings in
sleep and wake EEGs. An early study observed lower delta waves during sleep in depressed patients
without excluding for sleep disturbances [10]. In a similar vein, this finding was later observed in
MDD individuals, albeit only in men [5]. Conversely, we previously showed that young MDD women
devoid of co-morbid sleep disturbances exhibit higher, not lower, frontal non-REM delta EEG activity
(0.75–4.5 Hz), a classical marker of homeostatic sleep pressure, during both baseline and recovery
sleep subsequent to SD, as compared to that of healthy young and older women [11,12]. Furthermore,
MDD women exhibited higher frontal low-frequency (FLA) wake EEG activity (0.5–5.0 Hz) during SD
than that of healthy controls, particularly during the biological night [13]. Together, these data indicate
that young, moderately depressed women without sleep disturbances do not exhibit a deficiency
in the sleep homeostatic process S, as predicted by the S-deficiency hypothesis, but may rather live
on an elevated level of homeostatic sleep pressure [11,12]. Thus, concurrent sleep disturbances may
play a key role both in the pathophysiology of depression and in the antidepressant response to
SD. Importantly, these findings may speak to the plethora of different depression subtypes and the
underlying differences in sleep-wake regulation associated with these subtypes.
It still remains to be established if the antidepressant effects of SD are correlated with an
amelioration of the proposed S-deficiency [3,4] and thereby with brief improvements in sleep quality,
or if SD independently acts as an antidepressant. Thus, we investigated if differential sleep pressure
levels (high vs. low), as a marker of the sleep homeostatic process, would have significant repercussions
on self-rated mood in young women diagnosed with major depressive disorder (MDD) without sleep
disturbances, as compared to age-matched healthy control women. Our main predictions were
as follows:
1. Under high sleep pressure: MDD women without sleep disturbances will exhibit improvement
in subjective mood during the course of a 40-h SD (high sleep pressure conditions), as compared
to that of healthy control women. The SD-mood enhancement may occur due to the postulated
deficiency in S-process in MDD individuals. Furthermore, the comparison to healthy age- and
sex matched controls will allow us to tease apart how the SD-response is changed due to an
underlying MDD (without co-morbid sleep disturbances) symptomatology.
2. Under low sleep pressure conditions: subjective mood ratings will not differ between MDD and
control women during the course of a 40-h multiple NAP protocol, due to a minimal SD-response
in both groups, and will undergo a pronounced circadian modulation.
2. Experimental Section
2.1. Study Participants
Control and MDD women were recruited via advertisement at different Swiss universities and
through online job advertisement pages for students (for details see [13]). The rationale to include
only women was due to the fact that, typically, women are twice as likely to experience MDD as
compared to men. Considering that our study criteria included individuals that had MDD without
any medication and without co-morbid sleep disturbances, it was extremely difficult to recruit men
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(the ratio of 2:1 women:men in MDD with medication and co-morbid sleep disturbances may be even
more unbalanced given our study criteria) and to match both groups (MDD and controls) by age, sex,
and body mass index (BMI). Thus, only women were included in the current study.
Our in-laboratory study enrolled 16 young MDD women (age range 20–31 years; age: 24± 4.8 years,
mean ± standard deviation) who fulfilled the complete diagnostic criteria of the Diagnostic and
Statistical Manual (DSM-IV) for MDD [14]. These participants were randomly allocated to either the
low (n = 8) or high sleep pressure protocol (n = 8). This approach was used instead of a balanced
crossover design to ensure the two-fold methodological aspects: (1) No experimentally-induced
manipulation of prior sleep-wake history would potentially bias sleep-wake regulation and behavior
(subjective mood) in all MDD participants; (2) To guarantee that, at the time of admission to the
in-laboratory setting, all MDD participants had a stable clinical condition that would not be altered
due to sleep-wake manipulations.
They had neither atypical symptoms nor other co-morbid psychiatric DSM-IV-disorders, and
were without severe sleep problems as measured by the Pittsburgh Sleep Quality Index (PSQI≤ 8) [15]
(PSQI 5.5 ± 1.6). Each participant underwent a clinical interview with the same clinical psychologist
(ABP). This interview was comprised of the structured clinical interview for DSM-IV Axis I Diagnoses
of existing symptoms (SCID-I; 5.2 ± 0.4) [16]. The study volunteers had all of the following symptoms
at the time of the SKID Interview: “sadness”, “diminished interest or pleasure”, “energy loss”,
“reduced feeling of self-worth”, “diminished concentration”, and “social withdrawal”. Clinical status
was further estimated by the Structured Interview Guide for the Hamilton Depression Rating Scale
with Atypical Depression Supplement (SIGH-ADS) [17], which consists of the Hamilton-17 item scale
(Standard Value ≥ 8; 12.39 ± 2.5) plus atypical items including the Montgomery-Åsberg Depression
Scale [18] (MADRS: Standard Value ≥ 13; 16.7 ± 2.1) and the Beck Depression Inventory [19]
(BDI: Standard Value ≥12); 21.3 ± 6.8). Two weeks after study completion, there was a follow-up
assessment of the BDI (21.8 ± 9.1; n = 13), which confirmed the persistence of depressive symptoms.
The age-matched control group was comprised of eight healthy young women (age range
20–31 years; 25 ± 3.3 years) who were medically screened and had no prior psychiatric illness
(for further detailed information on the recruitment of the control women see [20,21]).
None of the study participants were taking any medication, nor were they undergoing any
type of medical or psychological treatment. All study participants were free of neurological and
other sleep disorders, as assessed by a full-night polysomnography screening (PSG). To exclude
chronotype-specific differences in circadian phase, only moderate chronotypes (morning-evening-type
questionnaire rating between 14 and 21 points [22]) were selected. However, depressive study
volunteers tended to be more evening types than healthy controls (16.1 ± 1.3 vs. 15.6 ± 3.7; p = 0.066,
t-test). Body mass index (BMI) did not significantly differ between the groups (21.2± 2.5 vs. 20.9 ± 1.4
for the healthy volunteers). All participants were non-smokers, without any drug abuse, and were
also required to abstain from heavy physical exercise and shift work before the study. All women
started the study on days 1–5 after menses onset in order to complete the entire study block within
the follicular phase, with the exception of three depressive and five control women who were
taking oral contraceptives. The reason to control for menstrual phase is due to the influence of
hormonal variations between follicular and luteal phases on readouts of the circadian timing system,
including core body temperature and melatonin, and sleep-wake regulation [23]. The choice to include
participants in the in-laboratory conditions during their follicular phase was due to the possible
dampening of amplitude in circadian oscillation during the luteal phase [24]. Furthermore, increased
daytime sleepiness in the luteal phase may be associated with increased daytime slow-wave sleep,
plausibly through changes in thermoregulation during the luteal phase [24]. Although controversy still
remains about the impact of different menstrual phases on outputs of sleep-wake regulation and the
circadian system, accounting for these differences is crucial. Thus, to avoid a potential bias of different
menstrual phases across participants impacting on key outputs of the circadian system, all participants
started their in-laboratory conditions under the same menstrual (follicular) phase. All procedures
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conformed to the Declaration of Helsinki and the local Ethical Committee (Ethikkommission beider
Basel, Basel, Switzerland).
2.2. Protocol and Study Design
Each participant was instructed to maintain a regular sleep–wake cycle (sleep- and wake-times
within ±30 min of self-selected target time), which was verified by wrist activity monitors (Cambridge
Neurotechnology®, Cambridge, UK) and sleep logs during the one week prior to the study. None of
our participants (healthy controls and MDD women) had sleep disturbances both subjectively and
objectively prior to participating to the study. This was guaranteed by excluding any participants
with a PSQI cut-off of 10 and above (which is deemed as clinically relevant poor sleep quality) and,
most importantly, by having a sleep polysomnography night (adaptation night) prior to admission
in the in-laboratory setting. Potential participant who had sleep efficiency below 80% and/or sleep
disorders (i.e., sleep apnea, periodic limb movements, restless legs, and so forth) were excluded as
study participants. The entire study design entailed two protocols: one for high and one for low sleep
pressure conditions. The eight healthy control women underwent a crossover design thus participating
in both protocols. In the depressive cohort, we recruited 16 study volunteers and distributed them
randomly to either the high or low sleep pressure protocol. Each protocol was comprised of 3.5 days
and started with an 8-h PSG night in the laboratory. During day 1, the study participants adjusted to the
experimental dim light condition (<8 lux). After a second 8-h sleep episode, participants underwent
either a high sleep pressure condition (40-h SD) or a low sleep pressure condition (40-h multiple
NAP protocol) under strictly controlled constant routine (CR) conditions [7,25], which was followed
by an 8-h recovery night sleep. The timing of the 8-h sleep episode was calculated with respect to
the midpoint of each individual’s habitual sleep episode as assessed by actigraphy and sleep logs
during the baseline week. All wake episodes were spent under semi-recumbent CR conditions during
wakefulness and supine posture during scheduled sleep episodes.
2.3. Mood Ratings
During the study paradigm, the time-course of subjective mood was assessed in the MDD women
by means of the Hamilton Depression Scale 7-Items (HAMD-7) German version analogous to [26] and
the Visual Analogue Scale (VAS) for subjective mood. Subjective mood was assessed by a 100 mm
bipolar visual analogue scale (VAS) at 30-min intervals in both MDD women and healthy controls.
Participants were asked to indicate how they felt “at the moment” by placing a vertical mark on
the VAS ranging from 0 (“worst ever”) to 100 mm (“best ever”). The VAS was administered every
30-min during scheduled wakefulness under a CR condition and every 30-min during the wake
episodes under the NAP condition. To allow for a direct comparison between the two conditions,
subjective mood ratings were collapsed into 3.75-h time bins per participant. Ultimately, this resulted
in individual mood data every ca. 4 h during both in-laboratory conditions. The HAMD-7 which has
been characterized for use in repeated short-term observer ratings, omitting sleep items that are not
relevant during SD, was only assessed in the MDD women. The HAMD-7 encompassed the items
“depressive mood”, “feeling of guilt”, “interest, pleasure, level of activity”, “tension and nervousness”,
“physical symptoms of anxiety”, “energy level”, and “suicide”. A score ≥4 indicates that a given
participant does not exhibit remission, while a score of ≤3 indicates full remission. This rating was
carried out during the baseline week before the laboratory protocol started, and at four time points:
at around 2 h (averaged time-of-day: 12 h) 14 h (21 h), 26 h (8 h), and 36 h (19 h) into the high or low
sleep pressure protocol.
2.4. Data Analyses and Statistics
The statistical packages SAS® (Version 6.12; SAS Institute Inc., Cary, NC, USA) and the
SPSS® (SPSS Inc., SPSS for Windows, Chicago, IL, USA, and Version 17) were used. For data
reduction, subjective mood ratings were collapsed into 3.75-h time bins per participant before
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averaging over participants Individual 3.75-h averages of subjective mood-ratings entered a three-way
repeated measure mixed-model analyses of variance (PROC MIXED, SAS) with main factors “group”
(MDD women vs. healthy control women), sleep pressure condition (high vs. low), and “time-of-day”
(11 time points). Since the three-way analyses on subjective mood did not yield significance for the
interaction of “sleep pressure condition”, “time-of-day”, and “group”, we applied a data reduction
approach, whereby two-way analyses with main factors “group” and “time-of-day” were performed
for each protocol (SD and NAP) sleep pressure condition separately. All p-values were based on
Huynh-Feldt’s (H-F) corrected degrees of freedom (significance level p < 0.05). Alpha adjustments for
multiple comparisons were applied with the Tukey-Kramer test, which was also used for post-hoc
comparisons. For the HAMD-7 observer ratings, a two-way repeated measure mixed-model analysis
of variance (PROC MIXED, SAS) with main factors “condition” (high and low sleep pressure) and
“time-of-day” (four time points) was applied. Lastly, diurnal changes in mood ratings were correlated
(Pearson Product Moment correlation) with PSQI scores in MDD and control women during SD.
3. Results
3.1. Effect of Differential Sleep Pressure Conditions on Subjective Mood
Average mood ratings across the low and high sleep pressure protocol were significantly lower
in MDD than that of control women (Figure 1) (factor group: MDD women vs. healthy control;
F1,21.4 = 17.88, p = 0.0004), whereas the factor “sleep pressure condition” and its interaction with the
factor “group” both did not yield significance.
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3.2. Time Course of Subjective Mood Levels under Different Sleep Pressure Conditions 
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Under low sleep pressure conditions, subjective mood yielded a significant group effect (F1,18.9 = 
17.5; p = 0.0005), a tendency for a time effect (F10,144 = 1.8; p = 0.07), and no significant interaction of 
these effects (F10,144 = 0.7; p = n.s), (Figure 2B). MDD women rated their mood significantly worse 
irrespective of time-of-day in the NAP protocol, while both groups showed a distinct diurnal pattern 
with lowest mood ratings during the biological night, when endogenous melatonin values were 
highest. 
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3.2. Time Course of Subjective Mood Levels under Different Sleep Pressure Conditions
The detailed time-course of mood ratings in 3.75-h time bins for MDD and control women is
illustrate in Figure 2. Und r high sleep pressure conditions, the time course of subjective mood
significantly varied for the main factors “group” (MDD women vs. healthy control; F1,19.7 = 17.2;
p = 0.0005), “tim elapsed” (11 time points, F10,136 = 3.6; p = 0.0003), and the interaction of these
two factors (F10,136 = 1.9; p = 0.04; Figure 2A). Post-hoc comparisons yielded significantly lo er mood
levels in MDD women during the second half of the night (4 a.m. and 8 a.m.).
Un er low sleep pressure conditions, subjective mood yielded a significant group effect
(F1,18.9 = 17.5; p = 0.0005), a tendency for a time effect (F10,144 = 1.8; p = 0.07), and no significant
interaction of these effects (F10,144 = 0.7; p = n.s), ( igure 2B). MDD women rated their mood significa tly
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worse irrespective of time-of-day in the NAP protocol, while both groups showed a distinct diurnal
pattern with lowest mood ratings during the biological night, when endogenous melatonin values
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3.3. Individual Time-Course of Subjective Mood
On a next step, we visually inspected individual time-courses for each participant (young controls
and MDD women). Under SD, 7/8 young controls had overall high mood levels (above cut-off of 50 in
the VAS) over 40 h and the single participant with lower mood levels had an average of around 45
(Figure S1A). Conversely, 7/8 MDD participants had low mood self-ratings (<50 in the VAS) at virtually
all time-points (Figure S1C). The single participant who had higher mood levels was not a statistical
outlier (within ±1 standard deviation from the group average). Under low sleep pressure conditions,
7/8 young controls had high mood levels (Figure S1B), whereas all MDD women had low mood
ratings across the entire study paradigm (Figure S1D). None of the MDD women had better mood on
day 2 than on day 1 of the SD protocol, thus no antidepressant effect was induced.
3.4. HAMD-7 Observer Ratings in MDDWomen
The time-course analysis of VAS mood self-ratings was complemented by analysis of the observer
ratings derived from the HAMD-7 questionnaire, whic indices core sympt ms of depression.
A tendency for significance was ob e ved for the main e fect “conditi ” (F3,26 = 1.1; p = 0.08),
such that nder low sl ep pressure, MDD wom n had fewer depression symptoms than under SD
(Figure S2). There were no significant differences for the main effect “time-of-day” and the interaction
of “condition” and “time-of-day”.
3.5. Sleep Deprivation Effect and Severity of PSQI Value in MDDWomen
Give the significant interaction between factors “group” and “time” and the visual inspection of
the individual moo curves during SD, we defined an index of “diurnality” by calculating the night-to
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daytime difference in mood ratings for each individual. To this end, we subtracted the night-time
rating at 4 a.m. (20-h after elapsed time awake) from the daytime rating at noon the next day (12 p.m.;
28-h after elapsed time awake) during high sleep pressure conditions (i.e., SD). A linear regression
between the PSQI-values (indicator of sleep quality) and this diurnality index in subjective mood
yielded a significant r-value (r = 0.76; p < 0.03 (Figure 3) in MDD women but not in control women
(r = −0.47, n.s).
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first to the second non-Rapid eye movement sleep (NREM) episode], was investigated in 
unmedicated SD responders and SD non-responders [27], whereby a high delta sleep ratio was a 
positive predictor for SD response. We previously described that the same MDD women as in this 
analysis appear to live on a higher level of homeostatic sleep pressure, as indexed by NREM EEG 
slow-wave activity (SWA 0.75–4.5 Hz) during baseline sleep [11,12]. Recovery sleep at the end of the 
high and also low sleep pressure protocols also showed significantly higher SWA in the MDD women 
Figure 3. Linear regression between the values of the Pittsburgh Sleep Quality Index (PSQI) at baseline
and the values of mood change from the visual analogue scale in the high sleep pressure protocol for
MDD women (r = 0.76; p < 0.03). This figure shows the difference of subjective mood between clock
time 4 a.m. (20-h after elapsed time awake) and clock time 12 p.m. (28-h after elapsed time awake)
(see Figure 2, high sleep pressure protocol). X-axis: PSQI values; Y-axis, VAS of subjective mood.
Black dots correspond to individual participants.
4. Discussion
Our data do not support the two postulated hypotheses. First, in young, unmedicated women
with MDD and no sleep disturbances, total SD did not lead to a significant antidepressant effect, when
comparing subjective mood ratings (derived from a visual analogue scale) or the HAMD-7 items
observer rating from day 1 with those from day 2. Both scales documented a similar time course,
important for the validity of our findings. These results were further confirmed by the individual
time-courses, such that no MDD participants exhibited SD-related mood enhancement. Collectively,
the data suggest that SD yields no antidepressant effect in young depressive women with major
depression without concomitant sleep disturbances. Second, under the low sleep pressure conditions of
a NAP protocol, MDD women still had lower subjective mood ratings than control women. All groups
showed circadian modulation of mood independent of the sleep pressure condition.
The lack of SD-mood enhancement found may be related to the selected group of young depressed
women without sleep complaints. Our study sample was diagnosed according to DSM-IV [14] with
MDD without any sleep complaints, in order to study the underlying depressive pathophysiology not
related to sleep disorders (additionally, for this reason, participants were unmedicated). The findings
suggest that there may be differences in the mood-enhancing response to SD between MDD with and
without sleep disturbances.
Some studies have provided insights into sleep-related changes associated to MDD.
The distribution of slow-wave activity (SWA), as indexed by the delta sleep ratio [quotient of SWA
in the first to the second non-Rapid eye movement sleep (NREM) episode], was investigated in
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unmedicated SD responders and SD non-responders [27], whereby a high delta sleep ratio was a
positive predictor for SD response. We previously described that the same MDD women as in this
analysis appear to live on a higher level of homeostatic sleep pressure, as indexed by NREM EEG
slow-wave activity (SWA 0.75–4.5 Hz) during baseline sleep [11,12]. Recovery sleep at the end of the
high and also low sleep pressure protocols also showed significantly higher SWA in the MDD women
than in controls [11,12]. Moreover, MDD women responded with a stronger EEG synchronization in a
frequency range of 0.5–5 Hz during SD [13], which confirmed the higher delta waves during sleep,
but not the role of delta sleep as a positive predictor for the SD response. These results challenge a
generalized assumption that “Process S” is deficient in all MDD [3]. Conversely, a higher level of sleep
pressure may be a negative predictor of response to sleep deprivation. SD response may depend on
the degree of concomitant sleep disorder. Indeed, within the small group undergoing SD, worse sleep
in the PSQI correlated with a greater improvement on day 2.
If MDD women with no sleep disturbances appear to live under higher sleep pressure, one may
argue this “ceiling effect” does not allow for further increases in sleep pressure that would be triggered
by SD. Ultimately, this may account for the absence of SD-antidepressant effects. Interestingly,
selectively reducing slow-waves during sleep with low level acoustic stimuli (slow-wave deprivation;
SWD), without disrupting total sleep time, has been shown to acutely reduce moderate MDD
symptomatology [28]. Participants experienced a significant decrease in depressive symptoms
according to both self-rated and researcher-administered scales, which was correlated with the
overnight dissipation of frontal-central slow-wave activity (SWA) during baseline sleep and the
rebound in right frontal all-night SWA during recovery sleep [28]. Given these data, one could
speculate that MDD—when dissociated from co-morbid sleep disturbances—may be associated with
an overall higher sleep pressure, as compared to that of MDD associated with insomnia.
Insomnia complaints tend to precede the onset and recurrence of depression [29–31] in as many
as 40% of cases [32]. The risk of developing major depression is significantly increased in individuals
suffering from insomnia [33–35]. An important corollary is that subjectively reported better sleep
quality post-treatment is associated with lower rates of depression recurrence [36]. Apart from
sleep-wake impact on mood, the circadian timing system is a known key player on mood regulation
in both healthy [21] and depressed individuals [37]. Thus, both the duration of wakefulness and the
circadian pacemaker are likely involved in the regulation and dysregulation of mood [37]. Under low
sleep pressure conditions, the time-course across all MDD women (Figure 2) and their individual
data (Figure S1) both indicate lower mood variability over time, which may reflect a flatted circadian
variation of mood. Together, these observations suggest a critical role played by sleep-wake regulatory
and circadian mechanisms in the pathophysiology of depression.
Limitations to our current findings include the relatively low sample size, which warrant
replication in larger study cohorts, and the absence of a separate MDD cohort with insomnia, which
is the sleep disorder most frequently co-morbid to this depression subtype. By experimentally
manipulating prior sleep-wake history in this potential group, one might tease apart the potential
role that insomnia would have in SD-mood responses. Future studies are warranted to specifically
investigate this association on subjective mood in MDD individuals.
5. Conclusions
Our data indicate that MDD women without sleep disturbances did not exhibit an SD-induced
antidepressant response, suggesting that the mood enhancement response to sleep deprivation might
be related to the co-existence of sleep disturbances. Future studies are warranted to establish this
association in patients suffering from MDD but without concomitant sleep disturbances.
Supplementary Materials: The following are available online at www.mdpi.com/2079-7737/5/4/52/s1,
Figure S1: Individual time-course profiles of subjective mood, Figure S2: Time course of the Hamilton Depression
Rating Scale in MDD women.
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